Birmingham

44th EMWA Conference
2-6 May 2017
ICC, Birmingham, UK

Professional development and networking
for medical writers at all stages in their careers

49 EPDP training workshops, covering a wide range of medical writing topics
6 expert seminars
1-day symposium: Transparency and Disclosure of Clinical Regulatory Documentation
Early morning, lunchtime and afternoon short seminars
Freelance business forum
Internship forum
Networking opportunities
Poster presentations
Social events
  And more...

 

See the programme for full details. We look forward to seeing you in Birmingham.

 

Read the message from the President and Conference Director

Dear Colleagues

On behalf of the EMWA Executive Committee, we have great pleasure in welcoming you to the 44th EMWA Conference at the International Conference Centre in Birmingham, UK, from Tuesday 2 May to Saturday 6 May 2017.

The EMWA Professional Development Committee have prepared a comprehensive education programme, with 32 foundation and 17 advanced level workshops covering a broad range of familiar and new topics.

Important developments regarding data transparency have occurred in the last few years. The EU adopted a new Regulation on Clinical Trials in 2014 which requires clinical study reports to be published and the first one was published in October 2016. Our 5th EMWA whole-day symposium entitled ‘Transparency and Disclosure of Clinical Regulatory Documentation’ will explore this important area. We will have the opportunity to hear speakers from regulatory bodies and the pharmaceutical industry as well as writers themselves.

For experienced members, we have a series of three expert seminars on the Wednesday and Friday morning of the conference that cover some of the latest developments in medical writing including: the role of medical writers in maximising the quality of publications and in organising successful medical conferences; considering patients’ needs in preparing pharmacovigilance documents; and writing responses to authorities and current industry requirements for clinical study protocols.

The conference will also host a lunchtime seminar on clinical trial disclosure requirements, an internship forum, an introductory talk for new writers and those considering joining the profession, and our well-established freelance business forum. Delegates can start their day with morning seminars, join our first session on mindfulness for medical writers, and take part in a range of exciting evening social events. There really is something for everyone.

We would like to thank our head office and team of committee members, workshop leaders and all the volunteers who have been working for many months to bring you this conference as well as the Pharmacovigilance and Regulatory Public Disclosure Special Interest Groups who have worked with us to identify such a broad range of interesting speakers.

We wish you all an interesting and enjoyable conference.

 

Alison Rapley

Slávka Baróniková

President

Conference Director

 

Registration

Conference Registration Non-Member ESS Registration